Difference between revisions of "Pharm Tech Minutes 2022.09.15"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
|||
(One intermediate revision by the same user not shown) | |||
Line 9: | Line 9: | ||
== 10:00 - 13:00 Medication documentation == | == 10:00 - 13:00 Medication documentation == | ||
− | + | * Presentation about the components that could be included in medication list. | |
− | + | * The medication management document of ISO TR 20831 also describes the flow and the components. | |
+ | * It is not useful to restart this discussion, but we should focus on the actors and transactions. | ||
+ | * We should also reuse material that has been produced by HL7 Pharmacy. | ||
== 13:00-14:00 Lunch == | == 13:00-14:00 Lunch == | ||
Line 38: | Line 40: | ||
== 16:00- 17:30 Prescription == | == 16:00- 17:30 Prescription == | ||
− | + | * Discussion about roles and actors | |
+ | * Specifically the role of pharmaceutical advisor. | ||
+ | * Should this be eliminated? | ||
+ | * That does not the necessity for transactions to adjust, stop or suggest a prescription. | ||
+ | * Jose will work out a proposal. | ||
== 17:30 Adjourn == | == 17:30 Adjourn == |
Latest revision as of 09:58, 15 September 2022
Agenda
Meeting Venue
Montreux
9:30 Welcome
- Review and Approve Agenda
10:00 - 13:00 Medication documentation
- Presentation about the components that could be included in medication list.
- The medication management document of ISO TR 20831 also describes the flow and the components.
- It is not useful to restart this discussion, but we should focus on the actors and transactions.
- We should also reuse material that has been produced by HL7 Pharmacy.
13:00-14:00 Lunch
14:00- 15:30 Adverse Event Reporting
- Adverse events There are two level of adverse events:
- Reporting
- Investigation.
Conclusion: Focus on the reporting part of adverse events. There are some adverse events reports that are mandatory on the national level in Switzerland. Conclusion: There is a need for adverse events on the national level. WHO want to give this more priority Action: we should ask the WHO to support the development of the logical data model for adverse events. OPEN IHE to support the transaction. Physicians are afraid that if they do the reporting they also need to do the investigation See an example of the Greece yellow carte: https://www.eof.gr/assets/KITRINI_KARTA.pdf
Number regarding adverse events:
- According to Leonidas only 10% of the reaction are being reported in Greece.
- In Portugal and Greece the doctors are the main source of the adverse events reports.
- In the Netherlands the patients are also contributing to the reports.
- In Austria the adverse events are not on the agenda. Hospitals have some things organised but the topic is not present due to other prioritisations.
Links to documents
15:30- 16:00 Break
16:00- 17:30 Prescription
- Discussion about roles and actors
- Specifically the role of pharmaceutical advisor.
- Should this be eliminated?
- That does not the necessity for transactions to adjust, stop or suggest a prescription.
- Jose will work out a proposal.